
Quince Therapeutics
A biopharmaceutical company focused on developing novel therapies.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Quince Therapeutics, Inc. is a biopharmaceutical company. The company is focused on the development and commercialization of novel therapies.
Similar companies
A biotechnology company developing genetic therapies for rare disorders.
Shares Biotechnology, Pharmaceuticals
A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
Shares Biotechnology, Pharmaceuticals
A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.
Shares Biotechnology, Pharmaceuticals
Biopharmaceutical company developing T-cell therapies for solid tumor cancers.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- quincetx.com
- Headquarters
- South San Francisco, California, USA
- Founded
- 2020
- Business model
- B2B
Tech stack
Detected on quincetx.com, last scanned 11 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Jetpack / WP.com Stats
- CMS / Builders
- WordPress
- Hosting
- AWS
- Email provider
- Microsoft 365
- Video / media
- Vimeo
Quince Therapeutics scores 41. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Quince Therapeutics do?
They recently announced the settlement of outstanding obligations under a loan from the European Investment Bank (EIB), a significant milestone that allows them to advance their restructuring and explore strategic alternatives to maximize shareholder value.
Is Quince Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Quince Therapeutics is 59 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Quince Therapeutics

